Indication
Zebinix is indicated as adjunctive therapy in adults, adolescents and children aged above 6 years, with partial-onset seizures with or without secondary generalisation.
In other countries
The same active substances on other registers, the same brand first.
National listings
The national registers that list this EU medicine.



